MB

MPM BioImpact Portfolio holdings

AUM $874M
1-Year Est. Return 79.23%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+79.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$611M
AUM Growth
+$33.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
51
New
Increased
Reduced
Closed

Top Buys

1 +$18M
2 +$7.41M
3 +$6.74M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$6.34M
5
LQDA icon
Liquidia Corp
LQDA
+$4.34M

Top Sells

1 +$23M
2 +$14.8M
3 +$14.8M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$12.3M
5
OLMA icon
Olema Pharmaceuticals
OLMA
+$10.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBX
51
MBX Biosciences
MBX
$1.46B
-1,294,416